MOH insider plans 357-share sale in Form 144 notice

MOH filed a Form 144 notice covering a planned sale of restricted or control securities.

Rhea-AI Filing Summary

MOH filed a Form 144 notice covering a planned sale of restricted or control securities. An affiliated holder plans to sell 357 common shares of MOH through Piper Sandler & Co. on the NYSE, with an indicated aggregate market value of $50,536.00. The filing notes that 51,400,000 common shares were outstanding.

The shares to be sold come from equity grant awards, with 189 shares acquired on 01/01/2025 and 168 shares acquired on 04/01/2025, both from the company. By signing, the seller represents they are not aware of any undisclosed material adverse information about MOH’s current or prospective operations and references the possibility of a Rule 10b5-1 trading plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MOH Form 144 filing disclose?

The Form 144 discloses that an affiliated holder of MOH plans to sell 357 common shares on the NYSE through Piper Sandler & Co. with an aggregate market value of $50,536.00.

How many MOH shares are covered by this Form 144 sale?

The notice covers a proposed sale of 357 common shares of MOH.

What is the reported market value of the MOH shares to be sold?

The aggregate market value of the 357 MOH common shares to be sold is reported as $50,536.00.

How many MOH shares were outstanding according to the Form 144?

The filing states that 51,400,000 common shares of MOH were outstanding.

How and when were the MOH shares being sold originally acquired?

The shares come from grant awards: 189 shares acquired on 01/01/2025 and 168 shares acquired on 04/01/2025, both from the company.

Does the seller make any representation about undisclosed information in the MOH Form 144?

Yes. By signing, the seller represents that they do not know any material adverse information about MOH’s current or prospective operations that has not been publicly disclosed and may reference a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 01:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001649773
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MOLINA HEALTHCARE, INC.
SEC File Number	001-31719
Address of Issuer	200 OCEANGATE, SUITE 100 LONG BEACH CALIFORNIA 90802
Phone	5624353666
Name of Person for Whose Account the Securities are To Be Sold	Schapiro Richard M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Piper Sandler and Co 350 North 5th Street Minneapolis MN 55401	357	50536.00	51400000	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2025	Grant Awards	Company			189	01/01/2025	Grant Awards
Common	04/01/2025	Grant Awards	Company			168	04/01/2025	Grant Awards

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Dan Schmidt, as a duly authorized representative of Piper Sandler & Co Corporate & Venture Services FA, as attorney-in-fact Richard Schapiro
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)